$13.70
0.96[7.54%]
At close: Apr 25
$13.70
0[0.00%]
After Hours: 4:21PM EDT
Annovis Bio
(NYSE:ANVS)Annovis Bio Stock (NYSE:ANVS), Analyst Ratings, Price Targets, Predictions
Annovis Bio Inc has a consensus price target of $28, established from looking at the 14 latest analyst ratings. The last 3 analyst ratings were released from HC Wainwright & Co., HC Wainwright & Co., and Brookline Capital on April 2, 2024, March 21, 2024, and February 28, 2024. With an average price target of $23 between HC Wainwright & Co., HC Wainwright & Co., and Brookline Capital, there's an implied 67.88% upside for Annovis Bio Inc from these 3 analyst ratings.
Analyst Firms Making Recommendations1
HC Wainwright & Co.
Brookline Capital
Canaccord Genuity
Ladenburg Thalmann
1calculated from analyst ratings published within the last 3 years
Analyst Ratings for Annovis Bio
date | ticker | Buy Now | Company | Current price | Upside/Downside | Analyst Firm | Analyst & % Accurate | Price Target Change | Rating Change | Previous / Current Rating | Get Alert |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 04/02/2024 | ANVS | Buy Now | Annovis Bio | $13.70 | 118.98% | HC Wainwright & Co. | Raghuram Selvaraju | $30 → $30 | Maintains | Buy | Get Alert |
| 03/21/2024 | ANVS | Buy Now | Annovis Bio | $13.70 | 118.98% | HC Wainwright & Co. | Raghuram Selvaraju | → $30 | Reiterates | Buy → Buy | Get Alert |
| 02/28/2024 | ANVS | Buy Now | Annovis Bio | $13.70 | -34.31% | Brookline Capital | Tyler Bussian | → $9 | Downgrade | Buy → Hold | Get Alert |
| 12/29/2023 | ANVS | Buy Now | Annovis Bio | $13.70 | 162.77% | Canaccord Genuity | Sumant Kulkarni | → $36 | Initiates | → Buy | Get Alert |
| 11/28/2023 | ANVS | Buy Now | Annovis Bio | $13.70 | 118.98% | HC Wainwright & Co. | Raghuram Selvaraju | → $30 | Reiterates | Buy → Buy | Get Alert |
| 11/13/2023 | ANVS | Buy Now | Annovis Bio | $13.70 | 118.98% | HC Wainwright & Co. | Raghuram Selvaraju | $40 → $30 | Maintains | Buy | Get Alert |
| 11/10/2023 | ANVS | Buy Now | Annovis Bio | $13.70 | 155.47% | Brookline Capital | Tyler Bussian | → $35 | Initiates | → Buy | Get Alert |
| 08/15/2023 | ANVS | Buy Now | Annovis Bio | $13.70 | 191.97% | HC Wainwright & Co. | Raghuram Selvaraju | → $40 | Reiterates | Buy → Buy | Get Alert |
| 06/28/2023 | ANVS | Buy Now | Annovis Bio | $13.70 | 191.97% | HC Wainwright & Co. | Raghuram Selvaraju | → $40 | Reiterates | Buy → Buy | Get Alert |
| 06/09/2023 | ANVS | Buy Now | Annovis Bio | $13.70 | 191.97% | HC Wainwright & Co. | Raghuram Selvaraju | → $40 | Reiterates | Buy → Buy | Get Alert |
| 04/21/2023 | ANVS | Buy Now | Annovis Bio | $13.70 | 191.97% | HC Wainwright & Co. | Raghuram Selvaraju | → $40 | Reiterates | → Buy | Get Alert |
| 02/08/2023 | ANVS | Buy Now | Annovis Bio | $13.70 | 191.97% | HC Wainwright & Co. | Raghuram Selvaraju | → $40 | Reiterates | → Buy | Get Alert |
| 09/08/2022 | ANVS | Buy Now | Annovis Bio | $13.70 | 191.97% | HC Wainwright & Co. | Raghuram Selvaraju | → $40 | Initiates | → Buy | Get Alert |
| 05/02/2022 | ANVS | Buy Now | Annovis Bio | $13.70 | 170.07% | Ladenburg Thalmann | Aydin Huseynov | → $37 | Initiates | → Buy | Get Alert |
FAQ
What is the target price for Annovis Bio (ANVS)?
The latest price target for Annovis Bio (NYSE: ANVS) was reported by HC Wainwright & Co. on April 2, 2024. The analyst firm set a price target for $30.00 expecting ANVS to rise to within 12 months (a possible 118.98% upside). 10 analyst firms have reported ratings in the last year.
What is the most recent analyst rating for Annovis Bio (ANVS)?
The latest analyst rating for Annovis Bio (NYSE: ANVS) was provided by HC Wainwright & Co., and Annovis Bio maintained their buy rating.
When was the last upgrade for Annovis Bio (ANVS)?
There is no last upgrade for Annovis Bio.
When was the last downgrade for Annovis Bio (ANVS)?
The last downgrade for Annovis Bio Inc happened on February 28, 2024 when Brookline Capital changed their price target from N/A to $9 for Annovis Bio Inc.
When is the next analyst rating going to be posted or updated for Annovis Bio (ANVS)?
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Annovis Bio, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Annovis Bio was filed on April 2, 2024 so you should expect the next rating to be made available sometime around April 2, 2025.
Is the Analyst Rating Annovis Bio (ANVS) correct?
While ratings are subjective and will change, the latest Annovis Bio (ANVS) rating was a maintained with a price target of $30.00 to $30.00. The current price Annovis Bio (ANVS) is trading at is $13.70, which is out of the analyst’s predicted range.
Browse analyst ratings and price targets on all stocks.